E.g., 07/18/2024
E.g., 07/18/2024

Growing Global 2016

19 September, 2016

Foreign-Direct Investment Growing Global is the St. Louis region's premier event for the international business community.

Education, Awareness, Celebration of Sepsis Families and the Outstanding Contributions to Sepsis Early Detection: bioMérieux, Inc. Releases National Sepsis Month 2016 Activities

14 September, 2016

Back-to-back events and symposia making National Sepsis Awareness Month 2016 the most eventful since Sepsis Month was launched 5 years ago!

bioMérieux – First-Half 2016 Results

31 August, 2016

The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on August 30 under the chairmanship of Jean-Luc Belingard and approved the consolidated financial statements for the six months ended June 30, 2016. The statements had been reviewed by the Statutory Auditors.

bioMérieux Submits 510(k) Application to the FDA for BacT/ALERT® VIRTUO™ Next Generation Automated Blood Culture system

02 August, 2016

The new system demonstrates bioMérieux’s commitment to automated blood culture - a foundational step to infectious disease diagnosis

bioMérieux – Second-Quarter 2016 Business Review

18 July, 2016

Marcy l'Etoile (France), July 18, 2016 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its quarterly business review for the six months ended June 30, 2016.

bioMérieux launches at ASM Microbe 2016: www.antimicrobial-resistance.biomerieux.com, its new website dedicated to Antimicrobial Resistance

16 June, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce the launch, on the occasion of the ASM Microbe 2016 (June 16-20, Boston), of its dedicated educational website on antimicrobial resistance.

bioMérieux 2015 Annual Report

08 June, 2016

In 2015, bioMérieux delivered a solid performance in terms of both sales and operating income, perfectly in line with the objectives we set for the business.

bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products

01 June, 2016

 bioMérieux, a global player in in vitro diagnostics and world leader in industrial microbiological control, announces the acquisition of Hyglos, a Bernried (Germany) - based company specializing in the detection of endotoxins.

Third Annual Step-On-Sepsis™ 5K Event on May 7th Recognized by state of North Carolina as “Sepsis Awareness Day”

02 May, 2016

bioMerieux and Sepsis Alliance co-sponsor the largest NC fundraiser designed to raise awareness on the importance of prevention through early detection of sepsis, the 10th Leading Cause of Death in the U.S.

Sepsis Alliance and bioMérieux, Inc. Partner for Sepsis Awareness and Prevention

25 April, 2016

bioMérieux and Sepsis Alliance announce collaboration on events to raise awareness, educate about the risk of sepsis, and share best practices with hospitals and physicians

Pioneering Diagnostics